| Lymphangioleiomyomatosis, a Study on Cathepsin K (NCT05323370) | University Hospital, Tours | 2022-05-31 |
| Effect of Loratadine in Lymphangioleiomyomatosis (NCT05190627) | Institut d'Investigació Biomèdica de Bellvitge | 2021-11-01 |
| Characterizing LAM With 11C-Choline PET/CT (NCT05087134) | Peking Union Medical College Hospital | 2021-11-01 |
| Sleep Patterns in Patients Affected by Lymphangioleiomiomatosis (NCT04577937) | dr. Stefano Nava | 2020-06-30 |
| Benefits of Pulmonary Rehabilitation in Patients With Severe Lymphangioleiomyomatosis (LAM) (NCT04184193) | Schön Klinik Berchtesgadener Land | 2019-12-03 |
| Biomarkers for Tuberous Sclerosis Complex (BioTuScCom) (NCT02654340) | CENTOGENE GmbH Rostock | 2018-08-01 |
| Resveratrol and Sirolimus in Lymphangioleiomyomatosis Trial (NCT03253913) | University of Cincinnati | 2018-03-31 |
| LAM Pilot Study With Imatinib Mesylate (NCT03131999) | Medical University of South Carolina | 2018-01-23 |
| Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial (NCT03150914) | University of Cincinnati | 2018-01-01 |
| Discovery of Sirolimus Sensitive Biomarkers in Blood (NCT03304678) | National Heart, Lung, and Blood Institute (NHLBI) | 2017-12-04 |
| A Study of Nintedanib for LymphAngioleioMyomatosis (LAM) (NCT03062943) | IRCCS Multimedica | 2016-12-06 |
| The Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation (ECMO) on Coronary Oxygenation in Lung Transplantation Patients (NCT02859194) | Yonsei University | 2016-05-31 |
| Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma (NCT02325505) | InCor Heart Institute | 2016-04-01 |
| TSC Biosample Repository and Natural History Database (NCT05676099) | National Tuberous Sclerosis Association | 2016-01-01 |
| Safety and Durability of Sirolimus for Treatment of LAM (NCT02432560) | University of Cincinnati | 2015-03-01 |
| Safety of Simvastatin in LAM and TSC (NCT02061397) | University of Pennsylvania | 2014-03-01 |
| Pulmonary Rehabilitation in Lymphangioleiomyomatosis (NCT02009241) | University of Sao Paulo General Hospital | 2013-11-01 |
| Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis (NCT01799538) | National Heart, Lung, and Blood Institute (NHLBI) | 2013-06-10 |
| Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease (NCT01552434) | M.D. Anderson Cancer Center | 2012-10-16 |
| Safety Study of Sirolimus and Hydroxychloroquine in Women With Lymphangioleiomyomatosis (NCT01687179) | Brigham and Women's Hospital | 2012-09-01 |
| National Lymphangioleiomyomatosis Registry, France (NCT01484236) | Vincent COTTIN | 2012-01-01 |
| Letrozole for Lymphangioleiomyomatosis (NCT01353209) | University of Cincinnati | 2011-05-01 |
| A Study to Determine the Safety and Effectiveness of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis (NCT01059318) | Novartis Pharmaceuticals | 2010-01-01 |
| Pulmonary Hypertension in Lymphangioleiomyomatosis (NCT00960895) | Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires | 2009-08-01 |
| Doxycycline In Lymphangioleiomyomatosis (LAM) (NCT00989742) | University of Nottingham | 2009-07-01 |
| Effect of Fasting on the Size of Abdominal Lymphatic Tumors in Women (NCT00552955) | National Heart, Lung, and Blood Institute (NHLBI) | 2007-10-26 |
| Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases (NCT00366509) | National Heart, Lung, and Blood Institute (NHLBI) | 2006-09-18 |
| Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM (NCT00490789) | Cardiff University | 2005-10-01 |
| RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM (NCT00457964) | Children's Hospital Medical Center, Cincinnati | 2005-08-01 |
| Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM (NCT00457808) | Children's Hospital Medical Center, Cincinnati | 2002-12-01 |
| Study of the Disease Process of Lymphangioleiomyomatosis (NCT00001465) | National Heart, Lung, and Blood Institute (NHLBI) | 1995-12-18 |